News

Investing.com -- Novo Nordisk (NYSE: NVO) has appointed Maziar Mike Doustdar as its new president and chief executive officer ...
Dr. Hodous, chief scientific officer, noted, “It has been deeply gratifying to witness the evolution of what began as a formidable scientific challenge—targeting SH2 domains as a therapeutic ...
Dr. Sinclair succeeds Dr. Gino Van Heeke, the former CSO, who is retiring, and, after ensuring a smooth leadership transition, will continue to support the company as a Scientific Advisor.
Roland Kolbeck, Ph.D. Appointed as Chief Scientific Officer - - Joe Monahan, Ph.D. will Continue to Support Aclaris as Special Scientific Advisor to the Chief Executive Officer through March 2026 ...
Professor Robin May will step down as the FSA’s Chief Scientific Adviser in September to become Interim Chief Scientific ...
Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for ...
CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Jun 9, 2025--Fable Therapeutics Appoints David J. Baker, PhD, as Chief Scientific Officer ...
NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment, with Melbourne-based exec Nathan Smith ...